WILMINGTON, Mass. & DUBLIN--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is the first company to offer clients Good Laboratory Practices (GLP) ...
Participants with worse clinical impairment compared with biological impairment often presented with other pathologies, such as α-synuclein positivity, higher NfL levels, advanced TDP-43-like ...
Analyzing several major pathology AI models designed to diagnose cancer, the researchers found unequal performance in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback